ADMA Biologics Mergers and Acquisitions Summary

Life Science Company

ADMA Biologics has acquired 1 company, including 1 in the last 5 years.

ADMA Biologics’ largest acquisition to date was in 2017, when it acquired Biotest Pharmaceuticals - US Therapy Business for $40M. ADMA Biologics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to ADMA Biologics’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1
  • M&A Advisors 3

ADMA Biologics, Inc.

465 Route 17 South,
Ramsey, New Jersey 07446
United States,
(201) 478-5552
www.admabiologics.com

ADMA is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the proposed treatment of Immune Deficiencies and the prevention and treatment of certain infectious diseases. ADMA's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. The target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. ADMA Biologics was formed in 2004 and is based in Ramsey, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.2/yr) # - 1 - - - - 1
vol $40M $40M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Biotest Pharmaceuticals Corp. - US Therapy Business 2017-01-23 40M USD Divestiture
, United States
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 40M (100%) - -
Total 1 $40M - -

By Geo

State/Country Buy Value Sell Value
United States 1 40M - -
Total 1 $40M - -

Top M&A Advisors

Financial Deals
Raymond James - Investment Banking
1
PJT Partners, Inc.
1
Legal Deals
Paul, Weiss, Rifkind, Wharton & Garrison LLP
1

Deal Values

buy # Total
< $100M 1 $40M
TOTAL $40M
Largest Biotest Pharmaceuticals Corp. - US Therapy Business
$40M (2017-01-23)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 164,024
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 153K M&A Transactions
  • 160K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 49K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.